Malignant peripheral nerve sheath tumor with perineurial differentiation

Malignant peripheral nerve sheath tumor with perineurial differentiation (MPNST with perineurial differentiation) is an extremely rare and aggressive subtype of malignant peripheral nerve sheath tumor (MPNST). MPNSTs are soft tissue sarcomas that arise from peripheral nerves or from cells associated with the nerve sheath, such as Schwann cells, fibroblasts, or perineurial cells. In this particular subtype, the tumor cells show differentiation toward perineurial cells, which are specialized cells that form the protective perineurium layer surrounding nerve fascicles. This distinction is made through immunohistochemical and ultrastructural analysis, with tumor cells typically expressing markers such as epithelial membrane antigen (EMA) and demonstrating characteristic perineurial features on electron microscopy. These tumors most commonly present as an enlarging, often painful mass along the course of a peripheral nerve, typically in the extremities, trunk, or head and neck region. They can affect surrounding soft tissues and may metastasize to distant sites, particularly the lungs. A significant proportion of MPNSTs arise in the context of neurofibromatosis type 1 (NF1), where pre-existing neurofibromas may undergo malignant transformation, though sporadic cases also occur. Symptoms may include a rapidly growing mass, neurological deficits such as numbness, weakness, or pain in the distribution of the affected nerve, and systemic symptoms if metastatic disease develops. Treatment follows the general approach for MPNSTs and typically involves wide surgical excision as the primary modality, with the goal of achieving clear margins. Adjuvant radiation therapy may be used to improve local control, particularly in cases where complete resection is difficult. The role of chemotherapy remains debated, though it may be considered for high-grade or metastatic disease, often using regimens similar to those for other soft tissue sarcomas (e.g., doxorubicin-based combinations). Prognosis is generally guarded, as MPNSTs are known for high rates of local recurrence and distant metastasis. The perineurial differentiation subtype is so rare that specific prognostic data for this variant are limited.

Common questions about Malignant peripheral nerve sheath tumor with perineurial differentiation